Relationship of extended upper mediastinal lymphadenectomy for esophageal cancer and recurrent laryngeal nerve palsy: a prospective study

Relationship of extended upper mediastinal lymphadenectomy for esophageal cancer and recurrent laryngeal nerve palsy: a prospective study - lymphadenectomy for esophageal cancer and recurrent laryngeal nerve palsy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007744

Enrollment

100

Registered

2012-04-13

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Esophagectomy without extended upper mediastinal lymphadenectomy Esophagectomy with extended upper mediastinal lymphadenectomy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) histologically proven adenocarcinoma (2) age 20-79 years (3) sufficient organ function

Exclusion criteria

Exclusion criteria: (1) Any patients judged to be unfit to participate in the study, by the investigator

Design outcomes

Primary

Measure	Time frame
Incidence of recurrent laryngeal nerve palsy	—

Secondary

Measure	Time frame
Overall survival, relapse-free survival and incidence of complication	—

Countries

Japan

Contacts

Public ContactHaruhiro Inoue, MD, PhD

Showa University Koto Toyosu Hospital Digestive Disease Center

haruinoue777@yahoo.co.jp03-6204-6000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026